NCT00687687
Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma
Phase: Phase 2
Role: Lead Sponsor
Start: May 31, 2008
Completion: Dec 31, 2011